Understand the source comparison
Best P21 Dosage for Cognitive Enhancement: Protocol Comparison
Daytime Neuroplasticity 15–20mg daily Subcutaneous Morning (within 30 min of waking) 6 weeks on, 4 weeks off Active learning periods, skill acquisition, language study Peak plasma levels align with waking cognitive work. Maximises task-specific neuroplastic ga
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Daytime Neuroplasticity
- 15–20mg daily
- Subcutaneous
- Morning (within 30 min of waking)
- 6 weeks on, 4 weeks off
- Active learning periods, skill acquisition, language study
- Peak plasma levels align with waking cognitive work. Maximises task-specific neuroplastic gains
- Sleep-Enhanced Consolidation
- 20–30mg daily
- 30–60 min before sleep
- Memory consolidation, procedural skill retention, exam prep
- Leverages natural GH surge during deep sleep. Compounds BDNF expression during REM cycles
- Low-Dose Maintenance
- 10mg daily
- Morning or evening
- 8 weeks on, 4 weeks off
- Baseline neuroprotection, aging mitigation, long-term brain health
- Below threshold for acute performance gains but sufficient for sustained CNTF upregulation
- Acute Performance Window
- 25mg single dose
- 60–90 min before high-cognitive-demand task
- As-needed (max 3x/week)
- Exam days, high-stakes presentations, intensive problem-solving sessions
- Not supported by long-term research. Acute dosing misses cumulative neuroplastic benefit